Healthcare professionals
On this page, you will find information on the European Medicines Agency’s (EMA) activities that are most relevant to healthcare professionals, including news and events.
You can contribute to EMA's work by responding to our public consultations.
Learn more about how how healthcare professionals are actively involved in EMA's work.
Featured information for healthcare professionals
EMA communication activities
We asked stakeholders for feedback on our communication activities in a survey in 2022 and captured the results in a newly-published report. The findings help us set targets, address areas for improvement and measure progress. For example, we are already adapting our messaging to better suit audience needs and are creating more visuals based on survey insights. We thank all respondents for their feedback.
EU agencies promoting a One Health approach
EMA and other scientific EU agencies responsible for human, animal health and environmental protection have established a task force to coordinate activities and share information, promoting a joined-up One Health approach. A paper is available containing more details.
Human medicines: highlights of 2022
In 2022, EMA recommended 89 medicines for marketing authorisation. Of these, 41 had a new active substance which had never been authorised in the European Union before. These included two vaccines and two treatments for COVID-19.
Guidance on medicine shortages
Guidance is available on the actions that patients and healthcare professionals can take to help prevent and manage shortages of human medicines in the EU. An infosheet and infocards are also available to summarise the recommendations in the guidance.
Questions and answers on interchangeability of biosimilars
A 'questions and answers' document is available for healthcare professionals, patients and other stakeholders to further address issues related to the interchangeability of biosimilars in EU countries. This complements the information that EMA and the Heads of Medicines Agencies provided in a joint statement on this topic, in September 2022.
European medicines agencies network strategy to 2025
The strategy sets out how the network will continue to enable the supply of safe and effective medicines, in the face of developments in science, medicine, digital technologies, globalisation and emerging health threats, such as the COVID-19 pandemic.
Latest news
Report on COVID-19 vaccine strain updates: global regulators agree on timing and data requirements
NewsHumanMedicinesVaccines
GLP-1 receptor agonists: available evidence not supporting link with suicidal and self-injurious thoughts and actions
NewsHumanMedicinesPharmacovigilanceReferrals
Due to planned system maintenance, several EMA applications will be fully or partially inaccessible from 11 to 17 April.
NewsCorporate
The European Medicines Agency's (EMA) office is closed from 18:30 on Wednesday 27 March 2024 to 07:30 on Tuesday 2 April 2024. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600.
NewsCorporate
Publications of interest
Video: Working for every patient in Europe
Watch our short video for a quick and easy explanation of who EMA is and what it does. (video in English, with subtitles in 24 different languages).
Video: 25 years of EMA engagement with patients and healthcare professionals
Watch our short video to see how our interactions with patients and healthcare professionals have evolved over the last 25 years (video in English).
EMA's 2022 annual report
Navigate through the digital report to view interviews, short videos and an interactive timeline of the Agency’s main activities in 2022. Read the traditional PDF version to see additional figures and statistics on EMA's regulatory procedures and activities.